Kamada (KMDA)
US Market

Kamada (KMDA) Stock Price & Analysis


KMDA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.72 - $5.72
Previous Close$4.83
Average Volume (3M)33.55K
Market Cap
Enterprise Value$196.49M
Total Cash (Recent Filing)$34.26M
Total Debt (Recent Filing)$6.62M
Price to Earnings (P/E)-94.0
Aug 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding44,832,843
10 Day Avg. Volume109,273
30 Day Avg. Volume33,549
Standard Deviation0.10
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)1.73
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.34
Enterprise Value/Gross Profit4.21
Enterprise Value/Ebitda43.46
Price Target Upside127.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Kamada’s price range in the past 12 months?
Kamada lowest stock price was $3.72 and its highest was $5.72 in the past 12 months.
    What is Kamada’s market cap?
    Currently, no data Available
    When is Kamada’s upcoming earnings report date?
    Kamada’s upcoming earnings report date is Aug 08, 2023 which is in 68 days.
      How were Kamada’s earnings last quarter?
      Kamada released its earnings results on May 24, 2023. The company reported $0 earnings per share for the quarter, missing the consensus estimate of $0.025 by -$0.025.
        Is Kamada overvalued?
        According to Wall Street analysts Kamada’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Kamada pay dividends?
          Kamada does not currently pay dividends.
          What is Kamada’s EPS estimate?
          Kamada’s EPS estimate is $0.02.
            How many shares outstanding does Kamada have?
            Kamada has 44,837,307 shares outstanding.
              What happened to Kamada’s price movement after its last earnings report?
              Kamada reported an EPS of $0 in its last earnings report, missing expectations of $0.025. Following the earnings report the stock price went up 15.385%.
                Which hedge fund is a major shareholder of Kamada?
                Among the largest hedge funds holding Kamada’s share is ARK Investment Management LLC. It holds Kamada’s shares valued at N/A.


                  Kamada Stock Smart Score

                  The Kamada stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the Proprietary Products segment and the Distribution segment. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Adamis Pharma
                  Clearside Biomedical
                  Eton Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis